39657-59-5

Upstream product

• 6828-16-6 3-methyl-5-methoxy-4-p-methylphenylazoisoxazole 
• 69059-67-2 5-methyl-2-p-tolyl-2H-[1,2,3]triazole-4-carboxylic acid ethyl ester 
• 69059-72-9 4-methoxycarbonyl-5-methyl-2-p-methylphenyl-2H-1,2,3-triazole 

Downstream Products

• 80957-38-6 (5-methyl-2-p-tolyl-2H-[1,2,3]triazol-4-yl)methanol 

Relevant academic research and scientific papers

PYRAZOLE DERIVATIVES

A compound represented by the general formula (I), which is useful as a peroxisome proliferator-activated receptor α/γ agonist, a salt of the compound, and a solvate of either. (In the formula, X, Y, and Z each represents nitrogen or carbon; m is an integ

N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia

NHE-1 inhibitors, methods of using such NHE-1 inhibitors and pharmaceutical compositions containing such NHE-1 inhibitors. The NHE-1 inhibitors are useful for the reduction of tissue damage resulting from tissue ischemia.

Methylation of 3-Methyl- and 3-Phenyl-4-arylhydrazonoisoxazol-5-ones with Diazomethane

3-Methyl(or phenyl)-4-arylhydrazonoisoxazol-5-ones on methylation with diazomethane afford 3-methyl(or phenyl)-4-(N-methylarylhydrazono)isoxazol-5-ones and 3-methyl(or phenyl)-5-methoxy-4-arylhydrazonoisoxazoles.The latter compounds readily rearrange to 4

Novel stilbene compounds

Stilbene compounds of the formula STR1 in which the rings A, B and C can carry non-chromophoric substituents, R1 is hydrogen, alkyl which is unsubstituted or substituted by non-chromophoric substituents, or aryl which is unsubstituted or substituted by non-chromophoric substituents, and R2 is a carboxyl group or a functional derivative thereof, a cyano group, a sulphonic acid ester group, a sulphonamide group or a sulphonyl group, and the use thereof as fluorescent brightening agents for high-molecular organic material.